Global Biologic Excipient Market Set to Reach USD 2,241.8 Million by 2034, Growing at a CAGR of 4.10%

The Global Biologic Excipient Market is projected to experience significant growth over the next decade, with an estimated market size of USD 1,500 million in 2024. By 2034, the market is expected to reach USD 2,241.8 million, reflecting a compound annual growth rate (CAGR) of 4.10% during the forecast period from 2024 to 2034.

Key Market Drivers
The growth of the biologic excipient market is primarily driven by the rising demand for biologics, which are increasingly being used in the treatment of chronic diseases, cancer, and autoimmune disorders. Biologic excipients play a crucial role in stabilizing and enhancing the efficacy of biologic drugs, making them indispensable in the pharmaceutical and biopharmaceutical industries.

The growing adoption of advanced drug formulations, coupled with increasing investments in biologics research and development, is expected to drive the demand for high-quality excipients. Additionally, regulatory advancements and the shift towards more personalized medicines are also contributing to market growth.

Key Takeaways

• Market Value in 2024: USD 1,500 million
• Projected Market Value by 2034: USD 2,241.8 million
• CAGR: 4.10% from 2024 to 2034
• Growth Drivers: Rising demand for biologic drugs, advancements in drug formulations, increasing investments in biologics R&D, and regulatory support.

Regional Insights

• North America: Leading the market with the largest share, driven by strong pharmaceutical infrastructure, high adoption rates of biologics, and robust research and development activities.
• Europe: Steady growth, with increasing demand for biologics in treating chronic and complex diseases, alongside supportive government regulations.
• Asia-Pacific: Rapid growth, particularly in emerging markets such as China and India, due to expanding pharmaceutical and biopharmaceutical sectors.
• Latin America & Middle East/Africa: Moderate expansion with an increasing focus on improving healthcare access and investments in biopharmaceutical industries.

Key Insights

Biologic excipients are critical components in the formulation of biologic drugs, enhancing their stability, delivery, and efficacy. The increasing demand for biologics in therapeutic applications is driving the growth of this market.

Growth Drivers

Several factors are contributing to the expansion of the biologic excipient market:

• Rising Demand for Biologics: The growing prevalence of chronic diseases and the need for targeted therapies are leading to an increased focus on biologic formulations.
• Advancements in Formulation Technologies: Innovations in excipient technologies are improving the performance and delivery of biologic drugs.
• Regulatory Support: Enhanced regulatory frameworks are facilitating the development and approval of biologic products, further driving market growth.

Biologic Excipient Market Growth Drivers

• Biologic medications are becoming increasingly preferred over conventional small-molecule medicines because of their high specificity, efficiency, and low adverse effects. The need for biologic excipients, which are essential for creating these cutting-edge treatments, is growing as a result of this trend.
• Clear regulatory pathways and supportive frameworks encourage investment in developing biologic excipients, fostering market growth.
• The rising shift towards personalized medicine and targeted therapies requires precise drug formulations tailored to individual patient needs.

Competitive Landscape

Companies in the biologic excipients industry are actively looking to bolster their positions through collaborations and acquisitions with established and up-and-coming competitors. Excipients are being produced in large quantities at local facilities by the manufacturers, who then sell them to biological drug producers at extremely low costs.

Leading companies in the field are concentrating on developing biologic excipients. Adopting IPEC principles is anticipated to encourage adherence to protocols, improving medicine efficacy and product safety in manufacturing and distribution.

• FMC Corporation offers a diverse portfolio of excipients used in pharmaceutical formulations, including biologic drugs. Their excipients are known for their high quality, functionality, and regulatory compliance.
• Wacker Chemie AG is a leading provider of specialty chemicals, including excipients for the pharmaceutical industry. They offer a range of excipients suitable for biologic drug formulations, including binders, fillers, and coatings.

Full Report Revealed

Key Companies Profiled

• FMC Corporation
• Wacker Chemie AG
• Evonik Industries AG
• Ashland Global Holdings Inc.
• Archer-Daniels-Midland Co.
• Roquette Freres S.A.
• The Dow Chemical Company
• Colorcon Inc.
• Signet Chemical Co. Pvt. Ltd.
• Sun Pharmaceutical Industries Ltd

Biologic Excipient Market Segmentation by Category

By Excipient Type:

• Polymers
• Sugar Alcohols
• Polysorbates
• Inorganic Salts
• Amino Acids
• Surfactants
• Others

By End User:

• Biopharmaceutical Manufacturers
• Contract Research Organizations
• Contract Manufacturing Organizations
• Research Organizations

By Region:

• North America
• Latin America
• Western Europe
• Eastern Europe
• South Asia and Pacific
• East Asia
• The Middle East and Africa

Author By:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube